136 related articles for article (PubMed ID: 15932723)
1. [The relationship between acute rejection and expression of sCD30 for the patients after kidney transplantation].
Yang JL; Hao HJ; Qin B; Bang LQ; Zhang ZH; Xin DQ; Guo YL; Na YQ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):651-3. PubMed ID: 15932723
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
3. Level of soluble CD30 after kidney transplantation correlates with acute rejection episodes.
Yang JL; Hao HJ; Zhang B; Liu YX; Chen S; Na YQ
Transplant Proc; 2008 Dec; 40(10):3381-3. PubMed ID: 19100394
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
Azarpira N; Aghdaie MH; Malekpour Z
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
[TBL] [Abstract][Full Text] [Related]
5. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
Dong W; Shunliang Y; Weizhen W; Qinghua W; Zhangxin Z; Jianming T; He W
Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
[TBL] [Abstract][Full Text] [Related]
6. High pretransplantation soluble CD30 levels: impact in renal transplantation.
Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
Wang D; Wu W; Yang S; Wang Q; Tan J
Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
[TBL] [Abstract][Full Text] [Related]
8. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
[TBL] [Abstract][Full Text] [Related]
9. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
11. [Influence of pre-transplant serum level of soluble CD30 on the long-term survival rates of kidney transplant recipients and grafts].
Chen JH; Lü R; Chen Y; Wu JY; He Q; Huang HF; Qu LH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1560-3. PubMed ID: 16179119
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation.
Valke LL; van Cranenbroek B; Hilbrands LB; Joosten I
Transpl Immunol; 2015 Jan; 32(1):18-22. PubMed ID: 25446808
[TBL] [Abstract][Full Text] [Related]
14. Value of soluble CD30 in liver transplantation.
Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
[TBL] [Abstract][Full Text] [Related]
15. sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil.
Weimer R; Süsal C; Yildiz S; Streller S; Pelzl S; Staak A; Renner F; Dietrich H; Daniel V; Feuring E; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
Transplant Proc; 2005 May; 37(4):1776-8. PubMed ID: 15919463
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of immune status of kidney transplant recipients by combined HLA-G5 and sCD30].
JIN ZK; TIAN PX; XUE WJ; DING XM; PAN XM; DING CG; JIA LN; GE GQ; HAO JJ
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2528-31. PubMed ID: 21092456
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of soluble serum CD30 in the diagnosis of early renal allograft dysfunction].
Trailin AV
Klin Khir; 2009 Oct; (10):44-6. PubMed ID: 20458950
[TBL] [Abstract][Full Text] [Related]
20. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
